Retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes

被引：21

作者：

Chen, TC

Yuen, SJA

Sangalang, MA

Fernando, RE

Leuenberger, EU

机构：

[1] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Glaucoma Serv, Boston, MA 02114 USA

[2] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA

[3] Univ E RMMMC, Dept Ophthalmol, Manila, Philippines

[4] St Martin Porres Char Hosp, Dept Ophthalmol, Manila, Philippines

[5] Rockwell Ctr, Asian Eye Inst, Dept Ophthalmol, Glaucoma Serv, Makati, Philippines

来源：

JOURNAL OF GLAUCOMA | 2002年 / 11卷 / 03期

关键词：

blind; chlorpromazine; painful; retrobulbar;

D O I：

10.1097/00061198-200206000-00008

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose: To report the efficacy of primary retrobulbar chlorpromazine injections for the management of blind and seeing painful eves. Patients and Methods: Retrospective case series from three university hospitals was done, Twenty eyes of 20 patients with at least 3 months of follow-up are reported. Ten of these 20 eyes did not receive any other ophthalmic medications either 2 weeks before chlorpromazine injection or at any time point after injection. Treatment was considered successful if pain control lasted for at least 3 months, without the need for reinjection or enucleation. Results: Sixteen of 20 (80.0%) eyes achieved successful pain control. There were no permanent complications in any patient. Conclusions: Retrobulbar chlorpromazine appears to be safe and effective for the management of pain in blind eyes.

引用

页码：209 / 213

页数：5